Source: University of Illinois at Urbana-Champaign From: news-medical.net A phase I clinical trial of PAC-1, a drug that spurs programmed cell death in cancer cells, found only minor side effects in patients with end-stage cancers. The drug stalled the growth of tumors in the five people in the trial with neuroendocrine cancers and reduced tumor size in two of those …
-
-
Your Wardrobe After Breast Cancer Treatments
-
What’s On the Outside Doesn’t Really Matter Even After Breast Cancer
-
You Had Breast Cancer And I Am So Mad At You
-
There’s Nothing Like Doing What You Most Love in Your Life
-
What To Expect After Your Breast Cancer Treatment Is Completed
